Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

An effective vaccine for respiratory syncytial virus (RSV) is an unrealized public health goal. A single dose of the prefusion-stabilized fusion (F) glycoprotein subunit vaccine (DS-Cav1) substantially increases serum-neutralizing activity in healthy adults. We sought to determine whether DS-Cav1 va...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Immunity
Asıl Yazarlar: Mukhamedova, Maryam, Wrapp, Daniel, Shen, Chen-Hsiang, Gilman, Morgan S.A., Ruckwardt, Tracy J., Schramm, Chaim A., Ault, Larissa, Chang, Lauren, Derrien-Colemyn, Alexandrine, Lucas, Sarah A.M., Ransier, Amy, Darko, Samuel, Phung, Emily, Wang, Lingshu, Zhang, Yi, Rush, Scott A., Madan, Bharat, Stewart-Jones, Guillaume B.E., Costner, Pamela J., Holman, LaSonji A., Hickman, Somia P., Berkowitz, Nina M., Doria-Rose, Nicole A., Morabito, Kaitlyn M., DeKosky, Brandon J., Gaudinski, Martin R., Chen, Grace L., Crank, Michelle C., Misasi, John, Sullivan, Nancy J., Douek, Daniel C., Kwong, Peter D., Graham, Barney S., McLellan, Jason S., Mascola, John R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099422/
https://ncbi.nlm.nih.gov/pubmed/33823129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2021.03.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller